JY
BME icon

Jeff Yass’s BlackRock Health Sciences Trust BME Stock Holding History

Jeff Yass’s Portfolio BME Stock Details BME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,192
Closed -$315K – 13408
2026
Q1 		$315K Buy
+8,192
New +$338K ﹤0.01% 10755

Other funds holding BME

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.15B AUM 12.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
NRW
Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Jeff Yass's BME Position: Q2 2026 in Review

Jeff Yass sold out of BlackRock Health Sciences Trust (BME) in Q2 2026, closing a stake of 8,192 shares — an estimated $315K sold.

Jeff Yass first reported a position in BME in Q1 2026 and held it in 1 quarter. The position peaked at $315K in Q1 2026. 79 funds tracked by Wall St. Rank hold BME as of Q2 2026.

  • Jeff Yass reported no remaining BlackRock Health Sciences Trust position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 8,192 BlackRock Health Sciences Trust shares in Q2 2026, an estimated $315K.
  • Jeff Yass first reported a position in BlackRock Health Sciences Trust in Q1 2026 and held it in 1 quarter.
  • Jeff Yass's BlackRock Health Sciences Trust position peaked at $315K in Q1 2026.
  • 79 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.